WeinzimerSA, SherrJL, CengizE, KimG, RuizJL, CarriaL, et al.Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes. Diabetes Care, 2012; 35: 1994–9.
2.
CersosimaE, CumminsMJ, KinzellJH, et al.A phase 2 comparative safety PK/PD study of stable non-aqueous glucagon (g-Pen) vs. Lilly glucagon for treatment of severe hypoglycemia. Diabetes, 2014; 63(suppl 1A): 1–LB.
3.
TurksoyK, et al.Classification of Physical Activity: Information to Artificial Pancreas Control Systems in Real Time. J Diabetes Sci Technol, 2015; 9: 1200–7.
4.
TrevittS, SimpsonS, WoodA. Artificial Pancreas Device Systems for the Closed-Loop Control of Type 1 Diabetes: What Systems Are in Development?. J Diabetes Sci Technol, 2016; 10: 714–23.
